DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Bernard Gallon, Dominique ^a,b   Bosviel, Rémy ^a,b   Delort, Laetitia ^a,b   Fontana, Luc ^c,d   Chamoux, Alain ^c,d   Rabiau, Nadège ^a,b   Kwiatkowski, Fabrice ^a,b   Chalabi, Nasséra ^a,b   Satih, Samir ^a,b   Bignon, Yves Jean ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GLUTAMINE; LYSINE; ORAL CONTRACEPTIVE AGENT; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA REPAIR; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HOMOZYGOSITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OVARY CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO; BREAST TUMOR; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; OVARY TUMOR; PATHOLOGY; RISK; RISK FACTOR;

BREAST NEOPLASMS; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 44349115538     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-36     Document Type: Article

References (38)

1. Helzlsouer KJ Harris EL Parshad R Perry HR Price FM Sanford KK DNA repair proficiency: Potential susceptiblity factor for breast cancer J Natl Cancer Inst 1996, 88:754-755. 10.1093/jnci/88.11.754 8637030
2. Coin F Marinoni JC Rodolfo C Fribourg S Pedrini AM Egly JM Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH Nat Genet 1998, 20:184-188. 10.1038/2491 9771713
3. Costa S Pinto D Pereira D Vasconcelos A Afonso-Lopes C Osorio T Lopes C Medeiros R Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer Cancer Lett 2007, 246:324-330. 10.1016/ j.canlet.2006.03.014 16677755
4. Lunn RM Helzlsouer KJ Parshad R Umbach DM Harris EL Sanford KK Bell DA XPD polymorphisms: Effects on DNA repair proficiency Carcinogenesis 2000, 21:551-555. 10.1093/carcin/21.4.551 10753184
5. Tang D Cho S Rundle A Chen S Phillips D Zhou J Hsu Y Schnabel F Estabrook A Perera FP Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer Breast Cancer Res Treat 2002, 75:159-166. 10.1023/ A:1019693504183 12243508
6. Justenhoven C Hamann U Pesch B Harth V Rabstein S Baisch C Vollmert C Illig T Ko YD Bruning T Brauch H ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population Cancer Epidemiol Biomarkers Prev 2004, 13:2059-2064. 15598761
7. Mitrunen K Hirvonen A Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat Res 2003, 544:9-41. 10.1016/S1383-5742(03)00016-4 12888106
8. Dumitrescu RG Cotarla I Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005, 9:208-221. 10.1111/ j.1582-4934.2005.tb00350.x 15784178
9. Bernard-Gallon DJ De Latour MP Sylvain V Vissac C Aunoble B Chassagne J Bignon YJ Brca1 and Brca2 protein expression patterns in different tissues of murine origin Int J Oncol 2001, 18:271-280. 11172592
10. Dumitrescu RG Cotarla I Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005, 9:208-221. 10.1111/ j.1582-4934.2005.tb00350.x 15784178
11. Innes KE Byers TE First pregnancy characteristics and subsequent breast cancer risk among young women Int J Cancer 2004, 112:306-311. 10.1002/ ijc.20402 15352044
12. Pathak DR Dual effect of first full term pregnancy on breast cancer risk: Empirical evidence and postulated underlying biology Cancer Causes Control 2002, 13:295-298. 10.1023/A:1015282916368 12074498
13. Russo J Russo IH Cellular basis of breast cancer susceptibility Oncol Res 1999, 11:169-178. 10566615
14. Killick S Eyong E Elstein M Ovarian follicular development in oral contraceptive cycles Fertil Steril 1987, 48:409-413. 3114009
15. Pelucchi C Galeone C Talamini R Bosetti C Montella M Negri E Franceschi S La Vecchia C Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies Am J Obstet Gynecol 2007, 196(1):83 e1 7. 10.1016/j.ajog.2006.06.088
16. Rodriguez C Calle EE Fakhrabadi-Shokoohi D Jacobs EJ Thun MJ Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women Cancer Epidemiol Biomarkers Prev 2002, 11:822-828. 12223425
17. Schouten LJ Goldbohm RA van den Brandt PA Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer Am J Epidemiol 2003, 157:424-433. 10.1093/aje/kwf224 12615607
18. Hirose K Tajima K Hamajima N Kuroishi T Kuzuya K Miura S Tokudome S Comparative case-referent study of risk factors among hormone-related female cancers in Japan Jpn J Cancer Res 1999, 90:255-261. 10359038
19. Riman T Dickman PW Nilsson S Correia N Nordlinder H Magnusson CM Persson IR Risk factors for epithelial borderline ovarian tumors: Results of a Swedish case-control study Gynecol Oncol 2001, 83:575-585. 10.1006/ gyno.2001.6451 11733975
20. Purdie DM Bain CJ Webb PM Whiteman DC Pirozzo S Green AC Body size and ovarian cancer: Case-control study and systematic review (Australia) Cancer Causes Control 2001, 12:855-863. 10.1023/A:1012267619561 11714114
21. Calle EE Rodriguez C Walker-Thurmond K Thun MJ Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 2003, 348:1625-1638. 10.1056/NEJMoa021423 12711737
22. Farrow DC Weiss NS Lyon JL Daling JR Association of obesity and ovarian cancer in a case-control study Am J Epidemiol 1989, 129:1300-1304. 2729264
23. Lubin F Chetrit A Freedman LS Alfandary E Fishler Y Nitzan H Zultan A Modan B Body mass index at age 18 years and during adult life and ovarian cancer risk Am J Epidemiol 2003, 157:113-120. 10.1093/aje/kwf184 12522018
24. Engeland A Tretli S Bjorge T Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women J Natl Cancer Inst 2003, 95:1244-1248. 12928351
25. Dal Maso L Franceschi S Negri E Conti E Montella M Vaccarella S Canzonieri V Parazzini F La Vecchia C Body size indices at different ages and epithelial ovarian cancer risk Eur J Cancer 2002, 38:1769- 1774. 10.1016/S0959-8049(02)00155-7 12175694
26. Fairfield KM Willett WC Rosner BA Manson JE Speizer FE Hankinson SE Obesity, weight gain, and ovarian cancer Obstet Gynecol 2002, 100:288-296. 10.1016/S0029-7844(02)02053-7 12151152
27. Kuper H Cramer DW Titus-Ernstoff L Risk of ovarian cancer in the United States in relation to anthropometric measures: Does the association depend on menopausal status? Cancer Causes Control 2002, 13:455-463. 10.1023/A:1015751105039 12146850
28. Wolk A Gridley G Svensson M Nyren O McLaughlin JK Fraumeni JF Adam HO A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 2001, 12:13-21. 10.1023/A:1008995217664 11227921
29. Moller H Mellemgaard A Lindvig K Olsen JH Obesity and cancer risk: A Danish record-linkage study Eur J Cancer 1994, 30A:344-350. 10.1016/ 0959-8049(94)90254-2 8204357
30. Slattery ML Schuman KL West DW French TK Robison LM Nutrient intake and ovarian cancer Am J Epidemiol 1989, 130:497-502. 2763995
31. Anderson JP Ross JA Folsom AR Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study Cancer 2004, 100:1515-1521. 10.1002/cncr.20146 15042687
32. Lukanova A Toniolo P Lundin E Micheli A Akhmedkhanov A Muti P Zeleniuch-Jacquotte A Biessy C Lenner P Krogh V Berrino F Hallmans G Riboli E Kaaks R Body mass index in relation to ovarian cancer: A multi-centre nested case-control study Int J Cancer 2002, 99:603-608. 10.1002/ijc.10374 11992553
33. Beehler GP Sekhon M Baker JA Teter BE McCann SE Rodabaugh KJ Moysich KB Risk of ovarian cancer associated with BMI varies by menopausal status J Nutr 2006, 136:2881-2886. 17056817
34. Greer JB Modugno F Ness RB Allen GO Anthropometry and the risk of epithelial ovarian cancer Cancer 2006, 106:2247-2257. 10.1002/cncr.21830 16596653
35. Delort L Kwiatkowski F Chalabi N Satih S Bignon YJ Bernard-Gallon DJ Risk factors for early age at breast cancer onset - the "COSA program" population-based study Anticancer Res 2007, 27:1087-1094. 17465248
36. Zhang L Zhang Z Yan W Single nucleotide polymorphisms for DNA repair genes in breast cancer patients Clin Chim Acta 2005, 359:150-155. 10.1016/j.cccn.2005.03.047 16002061
37. Livak KJ Allelic discrimination using fluorogenic probes and the 5' nuclease assay Genet Anal 1999, 14:143-149. 10084106
38. Kwiatkowski F Girard M Hacène K Berlie J Sem: A suitable statistical software adaptated for research in oncology Bull Cancer 2000, 87:715-721. 11084535